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An 83-year-old man, who worked as a bone collector in a cem-
etery, had medical history of chronic hepatitis C. He was admitted
to our hospital due to a persistent itchy sensation over his right up-
per limb after being struck by the branch of a pine tree. On physical
examination, there were multiple painful irregular-shaped ulcera-
tions on erythematous plaques with yellowish discharge over the
right forearm (Figure 1A). Laboratory investigations revealed a
white blood cell count of 7.3  109/L, hemoglobin 142 g/L, platelet
count 109 109/L, C-reactive protein 21.2 mg/L, and alanine amino-
transferase 2.76 g/L. Serum chemistry, such as prothrombin time,
serum albumin level, and serum bilirubin level, urinalysis, and
serologic evaluations of thyroid and renal functions were all within
the normal ranges. Serologic tests for rapid plasma reagin and hu-
man immunodeﬁciency virus were negative. Abdominal sonogra-
phy showed no obvious evidence of liver cirrhosis but right renal
cysts. Pathology of skin biopsy revealed skin tissue with a granulo-
matous inﬂammation in the dermis, and clusters of pigmented
spores and hyphae in multinucleated giant cells and microabscess
formation (Figure 2A and B). Cultures of the wounds over the right
arm and right forearm on separate days yielded Scedosporium apio-
spermum (Figure 1C and D). Slide culture stained with toluidine
blue revealed numerous single-celled, ovoid conidia, rounded
above with truncate bases. Conidia were borne singly or in small
groups on elongate, simple, or branched conidiophores or laterally
on hyphae. There were no seeding cleistothecia (ascocarps). The
ﬁnal diagnosis was cutaneous scedosporiosis.
Amphotericin B 50mg daily was prescribed. However, acute
renal failure with oliguria developed 4 days after treatment. Anti-
fungal agent was shifted to voriconazole 400 mg daily (8 mg/kg).
One week later, his skin lesions improved, leaving only slight
erosion over the right arm (Figure 1B). Due to symptoms of gastro-
intestinal upset that developed, the dosage of voriconazole was
decreased to 200 mg daily and continued for another week. Then,
icteric sclera developed. His family refused further antifungal treat-
ment owing to his age, persistent dyspepsia, and the potential liver
toxicity of the medication. However, recurrence of erosions and ul-
cerations were noted over the right arm days later. Voriconazole
200 mg daily (4 mg/kg) was reinitiated. Due to the deterioration
of hepatic function, voriconazole was then decreased to 75 mg
daily. Even under the adjusted dosage of voriconazole use, his
skin condition gradually improved, leaving only scaling. During
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faecalis. Finally, the patient died from septic shock even under sys-
temic antibiotics and a total of 11 weeks of voriconazole treatment.
Scedosporium apiospermum is a saprophytic fungus with a global
distribution, such as soil and stagnant water, agricultural land,
thorny shrubs, and in temperate climates.1,2 Scedosporium infec-
tions are uncommon, even in immunocompromised individuals.
Caira et al3 reported that overall incidence of Scedosporiosis was
about 0.08% in a 20-year retrospective survey of 8633 patients
with newly diagnosed acute leukemia in Italy. From 1995 to 2014,
there were only two reported cases of Scedosporium apiopermum
infection in Taiwan; one with mycetoma and the other with non-
mycetoma at presentation.1,4 However, increased frequency and
high mortality rates of invasive Scedosporium spp. infections were
noted in immunocompromised hosts.5 In an Australian surveillance
study of Scedosporiosis, skin/subcutaneous tissue accounted for
14.5% of the primary sites of infection.6 The most common skin
manifestations are multiple subcutaneous nodules in a sporotri-
choid distribution after injuries.1 Other rare skin manifestations
are nonemycetoma-like cutaneous and subcutaneous infections,
which present as necrotic ulcer encased by a circumferential area
of extensive skin sloughing, violaceous discoloration, and ery-
thema.3 A similarity in clinical presentation was noted between
our patient and that of the previously reported case mentioned
above.
Scedosporium apiospermum has been reported to have very high
levels of antifungal resistance, most notoriously to amphotericin B.7
Voriconazole is a compound with low minimal inhibitory concen-
tration values. Micafungin and posaconazole are reported to have
moderate activity against the majority strains of Scedosporium.7 A
combination of two antifungal agents with different mechanisms
or antifungal treatment used in combination with surgical inter-
vention may be warranted for intractable cases. The synergistic
interaction between azoles and terbinaﬁne blocks different steps
of the fungal ergosterol biosynthesis pathway. In a case report, sur-
gical debridement and intralesional injection of voriconazole (a
concentration of 3 mg/mL, once weekly for 2 weeks) were used
to treat successfully a patient with a hepatic contraindication for
voriconazole.8
Our patient had impaired liver function and underlying
chronic hepatitic C status so azole could only be used sparingly.
Extensive surgical debridement might not be appropriate for pa-
tients with advanced age. Intralesional injection of voriconazole
may be considered in such patients. In summary, this is the ﬁrst
formally reported case of non-mycetomatous S. apiospermum
infection in an immunocompetent patient in Taiwan, who
received oral voriconazole but eventually died of a hospital-
acquired infection.evier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1 (A)Multiplepainful irregular-shapedulcerations on erythematousplaqueswithyellowishdischarge over right forearm. (B) Small portion of erosionwith diffuse scaling andhealed
woundover right forearm. (C)Obverseviewofmacroscopiccolonymorphology:greyishewhite, suede-like todownycolony. (D)Microscopic examination revealed septate,hyalinebranching
cylindrical hyphaewith a single terminal conidia (uninucleate and cylindrical in shape) on branched conidiophores or laterally on hyphae (toluidine blue; original magniﬁcation200).(For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Figure 2 (A) Acute and chronic granulomatous inﬂammation in the dermis with clusters of pigmented spores and hyphae (black arrow) in multinucleated giant cells and micro-
abscess (hematoxylin and eosin; original magniﬁcation 400). (B) Further identiﬁcation of the spores and hyphae (black arrows; periodic acideSchiff; original magniﬁcation 400).
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